# MIBG Therapy for Patients With MIBG Avid Tumors

> **NCT02378428** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Nationwide Children's Hospital** · enrollment: 65 (estimated)

## Conditions studied

- MIBG Avid Tumors

## Interventions

- **DRUG:** MIBG

## Key facts

- **NCT ID:** NCT02378428
- **Lead sponsor:** Nationwide Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2014-03-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 65 (ESTIMATED)
- **Last updated:** 2025-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02378428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02378428, "MIBG Therapy for Patients With MIBG Avid Tumors". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02378428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*